Corvus Pharmaceuticals, Inc.
CRVS
$14.06
-$0.03-0.18%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 56.75M | 65.69M | 74.41M | 44.21M | 51.96M |
| Total Receivables | 374.00K | 346.00K | 259.00K | 227.00K | 216.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 173.00K | 223.00K | 333.00K | 507.00K | 470.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 917.00K | 686.00K | 781.00K | 545.00K | 1.76M |
| Total Current Assets | 58.21M | 66.94M | 75.78M | 45.49M | 54.41M |
|
|
|||||
| Total Current Assets | 58.21M | 66.94M | 75.78M | 45.49M | 54.41M |
| Net Property, Plant & Equipment | 1.06M | 1.15M | 1.26M | 1.26M | 1.33M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 855.00K | 852.00K | 626.00K | 629.00K | 632.00K |
| Total Assets | 71.12M | 80.47M | 89.46M | 59.44M | 68.91M |
|
|
|||||
| Total Accounts Payable | 2.49M | 1.97M | 3.14M | 1.31M | 2.58M |
| Total Accrued Expenses | 6.25M | 5.16M | 4.67M | 3.58M | 3.44M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 403.00K | 379.00K | 355.00K | 319.00K | 185.00K |
| Total Finance Division Other Current Liabilities | 238.00K | 566.00K | 346.00K | 4.08M | 29.20M |
| Total Other Current Liabilities | 238.00K | 566.00K | 346.00K | 4.08M | 29.20M |
| Total Current Liabilities | 9.38M | 8.07M | 8.51M | 9.28M | 35.40M |
|
|
|||||
| Total Current Liabilities | 9.38M | 8.07M | 8.51M | 9.28M | 35.40M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 534.00K | 632.00K | 728.00K | 834.00K | 937.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.91M | 8.71M | 9.23M | 10.11M | 36.34M |
|
|
|||||
| Common Stock & APIC | 474.39M | 472.80M | 471.19M | 432.40M | 430.87M |
| Retained Earnings | -412.29M | -399.97M | -389.82M | -381.82M | -397.01M |
| Treasury Stock & Other | -896.00K | -1.06M | -1.15M | -1.25M | -1.29M |
| Total Common Equity | 61.21M | 71.77M | 80.23M | 49.33M | 32.57M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 61.21M | 71.77M | 80.23M | 49.33M | 32.57M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 61.21M | 71.77M | 80.23M | 49.33M | 32.57M |
|
|
|||||